Clinical Trial Update: Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update comparing dexmedetomidine to nalbuphine for preventing emergence agitation after adenotonsillectomy in children (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Nalbuphine (nalbuphine)

Snippet

Sponsor: Ain Shams University | Conditions: Emergence Delirium | Phase 1, Phase 2 | Status: UNKNOWN